<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Seventy-two hours following a middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, the associated increase in water content on the ischemic side was significantly reduced by the exogenous administration of monosialoganglioside GM1 (30 mg/kg, i.p.) </plain></SENT>
<SENT sid="1" pm="."><plain>The levels of <z:chebi fb="40" ids="18243">dopamine</z:chebi> and <z:chebi fb="19" ids="28790">serotonin</z:chebi> on the ischemic side were approximately 50% and 80% of those on the contralateral non-ischemic side, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Treatment with GM1 (5 times during the first 48 h after occlusion) produced a significant reduction in the levels of <z:chebi fb="40" ids="18243">dopamine</z:chebi> and <z:chebi fb="19" ids="28790">serotonin</z:chebi> loss </plain></SENT>
<SENT sid="3" pm="."><plain>The present findings are compatible with the observed protective action of the exogenously administered GM1 following ischemic brain injury </plain></SENT>
</text></document>